In the yeast Saccharomyces cerevisiae, glucose or fructose represses the expression of a large number of genes. The phosphorylation of glucose or fructose is catalysed by hexokinase PI (Hxk1), hexokinase PII (Hxk2) and a specific glucokinase (Glk1). The authors have shown previously that either Hxk1 or Hxk2 is sufficient for a rapid, sugar-induced disappearance of catabolite-repressible mRNAs (short-term catabolite repression). Hxk2 is specifically required and sufficient for long-term glucose repression and either Hxk1 or Hxk2 is sufficient for long-term repression by fructose. Mutants lacking the TPS1 gene, which encodes trehalose 6-phosphate synthase, can not grow on glucose or fructose. In this study, suppressor mutations of the growth defect of a tps1delta hxk1delta double mutant on fructose were isolated and identified as novel HXK2 alleles. All six alleles studied have single amino acid substitutions. The mutations affected glucose and fructose phosphorylation to a different extent, indicating that Hxk2 binds glucose and fructose via distinct mechanisms. The mutations conferred different effects on long- and short-term repression. Two of the mutants showed very similar defects in catabolite repression, despite large differences in residual sugar-phosphorylation activity. The data show that the long- and short-term phases of catabolite repression can be dissected using different hexokinase mutations. The lack of correlation between in vitro catalytic hexokinase activity, in vivo sugar phosphate accumulation and the establishment of catabolite repression suggests that the production of sugar phosphate is not the sole role of hexokinase in repression. Using the set of six hxk2 mutants it was shown that there is a good correlation between the glucose-induced cAMP signal and in vivo hexokinase activity. There was no correlation between the cAMP signal and the short- or long-term repression of SUC2, arguing against an involvement of cAMP in either stage of catabolite repression.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1099/13500872-145-3-703 | DOI Listing |
Microorganisms
December 2024
Department of Civil and Environmental Engineering, University of Strathclyde, James Weir Building, Level 5, 75 Montrose Street, Glasgow G11XJ, UK.
The resistance of 16 strains to diesel fuel was studied. The minimal inhibitory concentrations of diesel fuel against were 4.0-64.
View Article and Find Full Text PDFFood Sci Biotechnol
January 2025
Department of Bioengineering and Technology, Kangwon National University, Chuncheon, Republic of Korea.
Unlabelled: was engineered to mitigate carbon catabolite repression to efficient co-fermenting mixed sugars, which are primary components of cellulosic biomass. KDH1 produced ethanol with 0.42 ± 0.
View Article and Find Full Text PDFBioresour Technol
December 2024
Leibniz Institute for Agricultural Engineering and Bioeconomy e. V. (ATB), Department Microbiome Biotechnology, Max-Eyth-Allee 100, Potsdam 14469, Germany. Electronic address:
Lignocellulosic media, containing diverse sugars and growth inhibitor compounds, pose great challenges to fermentation processes. This study tested thermophile Heyndrickxia coagulans strains for the production of L-(+)-lactic acid from waste wood hydrolysate. H.
View Article and Find Full Text PDFFEMS Microbiol Lett
January 2025
School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, China.
Int J Mol Sci
November 2024
Department of Molecular Science and Technology, Advanced College of Bio-Convergence Engineering, Ajou University, Woncheon-dong, Yeongtong-gu, Suwon 16499, Republic of Korea.
The gamma-ray-induced random mutagenesis of an engineered β-carotene-producing XL1-Blue resulted in the variant Ajou 45, which exhibits significantly enhanced β-carotene production. The whole-genome sequencing of Ajou 45 identified 55 mutations, notably including a reduction in the copy number of , encoding adenylate cyclase, a key enzyme regulating intracellular cyclic AMP (cAMP) levels. While the parental XL1-Blue strain harbors two copies of , Ajou 45 retains only one, potentially leading to reduced intracellular cAMP concentrations.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!